Jim Simons
IMVT icon

Jim Simons’s Immunovant IMVT Stock Holding History

Jim Simons’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.78M Buy
+192,500
New +$4.98M 0.01% 1411
2025
Q3 		– Sell
-241,400
Closed -$3.86M – 3690
2025
Q2 		$3.86M Sell
241,400
-154,500
-39% -$2.34M 0.01% 1678
2025
Q1 		$6.77M Buy
395,900
+315,000
+389% +$6.59M 0.01% 1234
2024
Q4 		$2M Sell
80,900
-108,100
-57% -$3.07M ﹤0.01% 2053
2024
Q3 		$5.39M Sell
189,000
-199,100
-51% -$5.87M 0.01% 1398
2024
Q2 		$10.2M Buy
388,100
+48,400
+14% +$1.38M 0.02% 906
2024
Q1 		$11M Buy
339,700
+321,400
+1,756% +$11.7M 0.02% 939
2023
Q4 		$771K Sell
18,300
-203,100
-92% -$7.47M ﹤0.01% 2561
2023
Q3 		$8.5M Sell
221,400
-246,400
-53% -$5.57M 0.01% 1015
2023
Q2 		$8.87M Sell
467,800
-24,312
-5% -$453K 0.01% 1093
2023
Q1 		$7.63M Buy
492,112
+148,012
+43% +$2.57M 0.01% 1234
2022
Q4 		$6.11M Sell
344,100
-8,400
-2% -$106K 0.01% 1393
2022
Q3 		$1.97M Buy
352,500
+19,900
+6% +$97.3K ﹤0.01% 2020
2022
Q2 		$1.3M Buy
332,600
+231,900
+230% +$1M ﹤0.01% 2530
2022
Q1 		$555K Buy
100,700
+83,100
+472% +$518K ﹤0.01% 3119
2021
Q4 		$150K Buy
+17,600
New +$145K ﹤0.01% 3606
2021
Q1 		– Sell
-5,600
Closed -$259K – 3492
2020
Q4 		$259K Buy
+5,600
New +$259K ﹤0.01% 3078
2020
Q3 		– Sell
-36,300
Closed -$884K – 3508
2020
Q2 		$884K Buy
+36,300
New +$778K ﹤0.01% 2601

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Jim Simons's IMVT Position: Q1 2026 in Review

Jim Simons opened a new position in Immunovant (IMVT) in Q1 2026: 192,500 shares worth $4.78M. The stake represents 0.01% of the portfolio and ranks #1411 among its holdings. This is a return to the name: Jim Simons previously reported a position in IMVT as recently as Q2 2025.

Jim Simons first reported a position in IMVT in Q2 2020 and has held it in 18 quarters since. The position peaked at $11M in Q1 2024. 215 funds tracked by Wall St. Rank hold IMVT as of Q1 2026.

  • Jim Simons held 192,500 shares of Immunovant worth $4.78M as of Q1 2026.
  • Immunovant was a new Jim Simons position in Q1 2026.
  • Immunovant made up 0.01% of Jim Simons's portfolio in Q1 2026, its #1411 holding.
  • Jim Simons first reported a position in Immunovant in Q2 2020 and has held it in 18 quarters since.
  • Jim Simons's Immunovant position peaked at $11M in Q1 2024.
  • 215 funds tracked by Wall St. Rank held Immunovant as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.